Efficacy of Immunomudulatory Therapy With All-trans Retinoid Acid for Adults With Chronic Immune Thrombocytopenia
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether All-trans retinoic acid (ATRA) are
effective in the treatment of refractory idiopathic thrombocytopenic purpura (RITP).
Details
Lead Sponsor:
First Affiliated Hospital of Suzhou Medical College